MNPR Monopar Therapeutics Inc.
Growth Rates

$0.68

Growth MetricsGrowth Grade and Underlying Metrics

Type	Grade	MNPR	Sector Median	% Diff. to Sector	MNPR 5Y Avg.	% Diff. to 5Y Avg.
Revenue Growth (YoY)	-Rating: Not Covered	-	6.65%	-	-	-
Revenue Growth (FWD)	-Rating: Not Covered	NM	9.13%	NM	-	-
EBITDA Growth (YoY)		-	4.20%	-	-	-
EBITDA Growth (FWD)		-	7.17%	-	-	-
EBIT Growth (YoY)		NM	2.83%	NM	NM	NM
EBIT Growth (FWD)		NM	7.33%	NM	-	-
EPS Diluted Growth (YoY)		NM	1.11%	NM	NM	NM
EPS Diluted Growth (FWD)		NM	8.18%	NM	-	-
EPS GAAP Growth (YoY)		NM	3.05%	NM	-	-
EPS GAAP Growth (FWD)		NM	11.45%	NM	-	-
EPS FWD Long Term Growth (3-5Y CAGR)		-	11.35%	-	-	-
Levered FCF Growth (YoY)		NM	9.89%	NM	NM	NM
Free Cash Flow Per Share Growth Rate (FWD)		-	13.07%	-	-	-
Operating Cash Flow Growth (YoY)		NM	10.57%	NM	NM	NM
Operating Cash Flow Growth (FWD)		-	11.81%	-	-	-
ROE Growth (YoY)		NM	-10.33%	NM	NM	NM
ROE Growth (FWD)		-	-1.00%	-	-	-
Working Capital Growth (YoY)		-44.45%	-11.74%	NM	32.21%	NM
CAPEX Growth (YoY)		-	-17.59%	-	-	-
Dividend Per Share Growth (FWD)		-	4.75%	-	-	-
1 Year Dividend Growth Rate (TTM)		-	5.29%	-	-	-

*Grades are relative to the Health Care sector

**NM signifies a non meaningful value. A dash signifies the data is not available.